145 related articles for article (PubMed ID: 35628658)
1. Genotoxicological Characterization of (±)cis-4,4'-DMAR and (±)trans-4,4'-DMAR and Their Association.
Lenzi M; Gasperini S; Cocchi V; Tirri M; Marti M; Hrelia P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628658
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').
Brandt SD; Baumann MH; Partilla JS; Kavanagh PV; Power JD; Talbot B; Twamley B; Mahony O; O'Brien J; Elliott SP; Archer RP; Patrick J; Singh K; Dempster NM; Cosbey SH
Drug Test Anal; 2014; 6(7-8):684-95. PubMed ID: 24841869
[TBL] [Abstract][Full Text] [Related]
3. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH
Neuropharmacology; 2018 Aug; 138():282-291. PubMed ID: 29908239
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).
McLaughlin G; Morris N; Kavanagh PV; Power JD; Twamley B; O'Brien J; Talbot B; Dowling G; Mahony O; Brandt SD; Patrick J; Archer RP; Partilla JS; Baumann MH
Drug Test Anal; 2015 Jul; 7(7):555-64. PubMed ID: 25331619
[TBL] [Abstract][Full Text] [Related]
5. Worsening of the Toxic Effects of (±)
Tirri M; Frisoni P; Bilel S; Arfè R; Trapella C; Fantinati A; Corli G; Marchetti B; De-Giorgio F; Camuto C; Mazzarino M; Gaudio RM; Serpelloni G; Schifano F; Botrè F; Marti M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445476
[TBL] [Abstract][Full Text] [Related]
6. 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.
Glanville J; Dargan PI; Wood DM
Hum Psychopharmacol; 2015 May; 30(3):193-8. PubMed ID: 25784180
[TBL] [Abstract][Full Text] [Related]
7. A validated, sensitive HPLC-MS/MS method for quantification of cis-para-methyl-4-methylaminorex (cis-4,4'-DMAR) in rat and human plasma: application to pharmacokinetic studies in rats.
Lucchetti J; Marzo CM; Di Clemente A; Cervo L; Gobbi M
Drug Test Anal; 2017 Jun; 9(6):870-879. PubMed ID: 27509066
[TBL] [Abstract][Full Text] [Related]
8. Brain Disposition of
Lucchetti J; Marzo CM; Passoni A; Di Clemente A; Moro F; Bagnati R; Gobbi M; Cervo L
J Pharmacol Exp Ther; 2017 Jun; 361(3):492-500. PubMed ID: 28404688
[No Abstract] [Full Text] [Related]
9. Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA.
Lenzi M; Gasperini S; Corli G; Marti M; Hrelia P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445675
[TBL] [Abstract][Full Text] [Related]
10. 4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.
Loi B; Zloh M; De Luca MA; Pintori N; Corkery J; Schifano F
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657180
[TBL] [Abstract][Full Text] [Related]
11. The Genotoxicity of Acrylfentanyl, Ocfentanyl and Furanylfentanyl Raises the Concern of Long-Term Consequences.
Gasperini S; Bilel S; Cocchi V; Marti M; Lenzi M; Hrelia P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430883
[TBL] [Abstract][Full Text] [Related]
12. Novel Psychoactive Phenethylamines: Impact on Genetic Material.
Cocchi V; Gasperini S; Hrelia P; Tirri M; Marti M; Lenzi M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348640
[TBL] [Abstract][Full Text] [Related]
13. 4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse.
Coppola M; Mondola R
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):26-30. PubMed ID: 25819702
[TBL] [Abstract][Full Text] [Related]
14. Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
Glennon RA; Misenheimer B
Pharmacol Biochem Behav; 1990 Mar; 35(3):517-21. PubMed ID: 1971111
[TBL] [Abstract][Full Text] [Related]
15. The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat.
Batsche K; Ashby CR; Lee C; Schwartz J; Wang RY
J Pharmacol Exp Ther; 1994 Jun; 269(3):1029-39. PubMed ID: 7912274
[TBL] [Abstract][Full Text] [Related]
16. Anthraquinones: Genotoxic until Proven Otherwise? A Study on a Substance-Based Medical Device to Implement Available Data for a Correct Risk Assessment.
Cocchi V; Gasperini S; Lenzi M
Toxics; 2022 Mar; 10(3):. PubMed ID: 35324767
[TBL] [Abstract][Full Text] [Related]
17. New probabilistic risk assessment of ethylhexyl methoxycinnamate: Comparing the genotoxic effects of trans- and cis-EHMC.
Nečasová A; Bányiová K; Literák J; Čupr P
Environ Toxicol; 2017 Feb; 32(2):569-580. PubMed ID: 27030676
[TBL] [Abstract][Full Text] [Related]
18. Genotoxic Properties of Synthetic Cannabinoids on TK6 Human Cells by Flow Cytometry.
Lenzi M; Cocchi V; Cavazza L; Bilel S; Hrelia P; Marti M
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050487
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cathinones - From natural plant stimulant to new drug of abuse.
Pieprzyca E; Skowronek R; Nižnanský Ľ; Czekaj P
Eur J Pharmacol; 2020 May; 875():173012. PubMed ID: 32087255
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro test systems using bacterial and mammalian cells for genotoxicity assessment within the "health-related indication value (HRIV) concept.
Prantl EM; Kramer M; Schmidt CK; Knauer M; Gartiser S; Shuliakevich A; Milas J; Glatt H; Meinl W; Hollert H
Environ Sci Pollut Res Int; 2018 Feb; 25(5):3996-4010. PubMed ID: 27928753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
